Evidence map›Paper›PMID 28513611›Full record

ArticleEuropean journal of human genetics : EJHG2017

Glaucoma spectrum and age-related prevalence of individuals with FOXC1 and PITX2 variants.

Emmanuelle Souzeau, Owen M Siggs, Tiger Zhou, Anna Galanopoulos, Trevor Hodson, Deepa Taranath, Richard A Mills, John Landers, John Pater, James E Smith and 12 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. In Vivo Assessment of Retinal Phenotypes in Axenfeld-Rieger Syndrome.Investigative ophthalmology & visual science · 2024
    Article
  10. Review
  11. Article
  12. Neuroimaging Findings in Axenfeld-Rieger Syndrome: A Case Series.AJNR. American journal of neuroradiology · 2023
    Article
  13. Article
  14. Adamts10 controls transforming growth factorFrontiers in molecular biosciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Emmanuelle SouzeauDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Owen M SiggsDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Tiger ZhouDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Anna GalanopoulosSouth Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Trevor HodsonMount Gambier Eye Centre, Mount Gambier, SA, Australia.
Deepa TaranathDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Richard A MillsDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
John LandersDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
John PaterDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
James E SmithDepartment of Ophthalmology, Children's Hospital at Westmead, Sydney, NSW, Australia.
James E ElderDepartment of Ophthalmology, Royal Children's Hospital, Melbourne, VIC, Australia.
Julian L RaitCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Paul GilesEye Clinic Albury-Wodonga, Albury, NSW, Australia.
Vivek PhakeyWaverley Eye Clinic, Glen Waverley, VIC, Australia.
Sandra E StaffieriDepartment of Ophthalmology, Royal Children's Hospital, Melbourne, VIC, Australia.
Lisa S KearnsCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Andrew DubowskySA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.
David A MackeyCentre for Ophthalmology and Visual Science, University of Western Australia, Lions Eye Institute, Perth, WA, Australia.
Alex W HewittCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Jonathan B RuddleDepartment of Ophthalmology, Royal Children's Hospital, Melbourne, VIC, Australia.
Kathryn P BurdonDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Jamie E CraigDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, SA, Australia.
Flinders University · AUFlinders Medical Centre · AUCentre for Eye Research Australia · AUUniversity of Melbourne · AUAlbury Wodonga Health · AUMacquarie University · AUMount Medical Centre · AURoyal Adelaide Hospital · AURoyal Children's Hospital · AUTissuPath · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variation in FOXC1 and PITX2 is associated with Axenfeld-Rieger syndrome, characterised by structural defects of the anterior chamber of the eye and a range of systemic features. Approximately half of all affected individuals will develop glaucoma, but the age at diagnosis and the phenotypic spectrum have not been well defined. As phenotypic heterogeneity is common, we aimed to delineate the age-related penetrance and the full phenotypic spectrum of glaucoma in FOXC1 or PITX2 carriers recruited through a national disease registry. All coding exons of FOXC1 and PITX2 were directly sequenced and multiplex ligation-dependent probe amplification was performed to detect copy number variation. The cohort included 53 individuals from 24 families with disease-associated FOXC1 or PITX2 variants, including one individual diagnosed with primary congenital glaucoma and five with primary open-angle glaucoma. The overall prevalence of glaucoma was 58.5% and was similar for both genes (53.3% for FOXC1 vs 60.9% for PITX2, P=0.59), however, the median age at glaucoma diagnosis was significantly lower in FOXC1 (6.0±13.0 years) compared with PITX2 carriers (18.0±10.6 years, P=0.04). The penetrance at 10 years old was significantly lower in PITX2 than FOXC1 carriers (13.0% vs 42.9%, P=0.03) but became comparable at 25 years old (71.4% vs 57.7%, P=0.38). These findings have important implications for the genetic counselling of families affected by Axenfeld-Rieger syndrome, and also suggest that FOXC1 and PITX2 contribute to the genetic architecture of primary glaucoma subtypes.

Indexed as

DNA Copy Number VariationsPenetranceAdolescentAdultAgedAge FactorsFemaleForkhead Transcription FactorsGlaucomaHeterozygoteHomeobox Protein PITX2Homeodomain ProteinsHumansMaleMiddle AgedPedigreeForkhead Transcription FactorsFOXC1 protein, humanHomeobox Protein PITX2Homeodomain ProteinsTranscription Factors

Identifiers

PMID28513611
PMCPMC5520071
OpenAlexW2614978215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.